Francesco de Rubertis, Director at Centessa Pharmaceuticals plc (CNTA), bought 67,856 shares at $12.82 ($870K) on 2021-12-02, disclosed to the SEC on 2021-12-06.
Open-market purchase of $870k CNTA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.82 | 796 | $10K | 1.2% |
| 2 | $12.82 | 33,530 | $430K | 49.4% |
| 3 | $12.82 | 33,530 | $430K | 49.4% |
| Total | $12.82 avg | 67,856 | $870K | 100% |
| Filing → |
| CNTA | BUY | 2021-06-04 | $12.0M | — | Filing → |
| NERV | SELL | 2016-08-12 | $10.0M | — | Filing → |
| NERV | BUY | 2015-03-20 | $975K | — | Filing → |